Obio Technology Shanghai Corp Ltd
SSE:688238
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.88
9
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Obio Technology Shanghai Corp Ltd
Total Current Assets
Obio Technology Shanghai Corp Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
O
|
Obio Technology Shanghai Corp Ltd
SSE:688238
|
Total Current Assets
ÂĄ927.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Total Current Assets
ÂĄ30.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
||
Pharmaron Beijing Co Ltd
SZSE:300759
|
Total Current Assets
ÂĄ7.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
||
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Total Current Assets
ÂĄ19.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
||
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Total Current Assets
ÂĄ7.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
27%
|
||
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Total Current Assets
ÂĄ5.2B
|
CAGR 3-Years
273%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Obio Technology Shanghai Corp Ltd
Glance View
Obio Technology Shanghai Corp. Ltd. engages in biomedical basic research, gene therapy drug incubation, and clinical grade gene therapy virus vector CDMO service provision. The company is headquartered in Shanghai, Shanghai and currently employs 631 full-time employees. The company went IPO on 2022-03-22. The firm is mainly engaged in providing contract research organization (CRO) services such as gene therapy vector development and gene function research for the basic research of gene therapy, as well as contract research and development production organization (CDMO) services such as pharmaceutical research and clinical sample production for the research and development of gene drugs. The firm mainly conducts business in the European and American markets and the domestic market.
See Also
What is Obio Technology Shanghai Corp Ltd's Total Current Assets?
Total Current Assets
927.4m
CNY
Based on the financial report for Dec 31, 2023, Obio Technology Shanghai Corp Ltd's Total Current Assets amounts to 927.4m CNY.
What is Obio Technology Shanghai Corp Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
73%
Over the last year, the Total Current Assets growth was -37%. The average annual Total Current Assets growth rates for Obio Technology Shanghai Corp Ltd have been 7% over the past three years , 73% over the past five years .